Health · 1 sources covering this

STAT+: Pharmalittle: We’re reading about a lawsuit over lab tests for meds, a Bristol myeloma drug, and more

The FDA approved a Bristol oral treatment for advanced multiple myeloma, marking the debut of a new class of medicine for the blood cancer

Share:X WhatsApp Reddit Facebook LinkedIn Open ↗

Coverage spectrum

0 L · 1 C · 0 R

How 1 sources are covering this

STATCenter·2h ago
STAT+: Pharmalittle: We’re reading about a lawsuit over lab tests for meds, a Bristol myeloma drug, and more
The FDA approved a Bristol oral treatment for advanced multiple myeloma, marking the debut of a new class of medicine for the blood cancer
Read at STAT →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://statesidedaily.com/embed/cluster/1e04bbf88282d93c87b98e8f3b29a2e4e67638cf"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="STAT+: Pharmalittle: We&#8217;re reading about a lawsuit over lab tests for meds, a Bristol myeloma drug, and more"></iframe>

STAT+: Pharmalittle: We’re reading about a lawsuit over lab tests for meds, a Bristol myeloma drug, and more

How 1 sources are covering this

STAT+: Pharmalittle: We’re reading about a lawsuit over lab tests for meds, a Bristol myeloma drug, and more

More from Health

STAT+: PBMs agree to display TrumpRx drug prices

The Taliban has taken a terrible toll on the education of girls -- and boys as well

STAT+: Drug-testing lab that has sparked controversy sues group that develops drug standards over criticism

STAT+: FDA approves Bristol multiple myeloma treatment, marking debut of novel drug class

Reader

Trust & legal

Across the network

How 1 sources are covering this

STAT+: Pharmalittle: We&#8217;re reading about a lawsuit over lab tests for meds, a Bristol myeloma drug, and more

More from Health

STAT+: PBMs agree to display TrumpRx drug prices

The Taliban has taken a terrible toll on the education of girls -- and boys as well

STAT+: Drug-testing lab that has sparked controversy sues group that develops drug standards over criticism

STAT+: FDA approves Bristol multiple myeloma treatment, marking debut of novel drug class

Reader

Trust & legal

Across the network

STAT+: Pharmalittle: We’re reading about a lawsuit over lab tests for meds, a Bristol myeloma drug, and more